Registry of Lobbyists
Version 5 of 8 (1998-08-11 to 1999-03-11) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP)
350 - 1145 HUNT CLUB ROAD OTTAWA, ON K1V 0Y3 Canada |
| Telephone number: | 613-736-9733 |
| Fax number: | 613-736-5660 |
| Responsible officer name and position during the period of this registration: | WILLIAM J LESLIE, EXECUTIVE DIRECTOR |
| Description of the organization's activities: | THE CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP) IS THE NATIONAL VOLUNTARY ORGANIZATION OF PHARMACISTS WHO SHARE AN INTEREST IN PHARMACY PRACTICE IN HOSPITALS AND RELATED HEALTH CARE SETTINGS.CSHP'S VISION IS: COMMITTED CAREGIVERS.... CHALLENGING EACH OTHER THROUGH SHARING & EDUCATION , LEADING PHARMACY THROUGH STANDARDS & INNOVATION. THE RELATED VISION OBJECTIVES ARE:1- ENCOURAGE MEMBERS TO DEVELOP & SHARE INNOVATIVE DIRECT PATIENT CARE PRACTIVE MODELS & EXPERIENCE2- PROMOTE THE DIRECT PATIENT CARE ROLE OF THE PHARMACIST TO: MEMBERS, PATIENTS, EDUCATORS, STUDENTS, GOV'T, HEALTH CARE PROVIDERS & ORGANIZATIONS3- PROVIDE ACCESSIBLE EDUCATION TO ASSIST MEMBERS IN ACHIEVING A DIRECT PATIENT CARE ROLE |
| Organization's membership or classes of membership: | 1- ACTIVE MEMBERS ARE PHARMACISTS LICENSED OR REGISTERED WITH A PHARMACY REGULATORY BODY IN CANADA OR PERSONS WITH A PROFESSIONAL DEGREE IN PHARMACY2- HONORARY MEMBERS - ELECTED BY A 2/3 VOTE OF THE COUNCIL OF THE SOCIETY3- STUDENT MEMBERS ARE PERSONS ENROLLED IN A BACCALAUREATE DEGREE PROGRAM IN PHARMACY4- SUPPORTING MEMBERS ARE PERSONS NOT ELIGIBLE FOR OTHER MEMBERSHIP CATEGORIES5- CORPORATE MEMBERS ARE CORPORATIONS WHO SUPPORT THE OBJECTIVES OF AND PAY FEES TO THE SOCIETY |
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | WILLIAM LESLIE |
| Position title: | EXECUTIVE DIRECTOR |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | DRUGS DIRECTORATE, HEALTH PROTECTION BRANCH, Environment Canada, Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Health |
| Subject Matter: Retrospective: | . REPRESENT CSHP ON TPP (THERAPEUTIC PRODUCTS PROGRAMME) ADVISORY PANEL ON ELECTRONIC TRANSFER OF INFORMATION (APETI). REPRESENT CSHP AT NATIONAL PHARMACARE AND NATIONAL HOMECARE CONFERENCES. CONTINUED WORK WITH TPP ON HOSPITAL COMPOUNDING VS. MANUFACTURING INITIATIVE. PMPRB MANDATE REVIEW (ALSO COMMENTED ON RULES OF OPERATION DISCUSSION PAPER).AS MEMBER OF "NATIONAL PHARMACY COALITION ON MANAGED CARE", DISCUSSIONS ON NIHB ISSUES. RESPONSES TO REQUESTS FOR COMMENT: TPP - PUBLICATION OF SPECIAL ACCESS PRODUCT INFORMATION; GMP REQUIREMENTS FOR SCHEDULE "D" DRUGS; AFFIRMATION OF CSHP POSITION ON DIRECT TO CONSUMER ADVERTISING; REPEAL OF DIVISON 20 REGULATIONS TO FOOD & DRUG ACT; SCHEDULE A AMENDMENTS REGARDING HEPATITIS; CHANGES TO CONTROLLED DRUG AND SUBSTANCES ACT; MEDICAL DEVICE COST RECOVERY REGULATIONS; RX TO OTC SWITCH OF ACETAMINOPHEN 650 MG SR; COMMENT ON DRUG PRODUCT MONOGRAPH TEMPLATE; PRODUCT LICENSING FRAMEWORK AND BIOAVAILABILITY STUDIES. BILL S-13 TOBACCO INDUSTRY RESPONSIBILITY ACT |
| Subject Matter: Prospective: | . CONTINUED REPRESENTATION ON TPP'S APETI. CONTINUED WORK WITH TPP ON HOSPITAL COMPOUNDING VS. MANUFACTURING. RESPONSES TO HEALTH RELATED ISSUES PUBLISHED IN CANADA GAZETTE. RESPONSE TO TPP REQUESTS FOR COMMENT & PARTICIPATION IN CONSULTATIVE WORKSHOPS. PARTICIPATION IN INITIATIVES WHICH MAY ARISE RELATED TO NATIONAL PHARMACARE & HOMECARE PROGRAMMES |